Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Granulocyte transfusion: current status.

Thomas H Price1

  • 1Puget Sound Blood Center and Department of Medicine, University of Washington, Seattle, WA 98104, USA. thprice@psbc.org

Seminars in Hematology
|January 3, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Neutropenia and infections: Neutrophil replacement through genetic engineering.

Journal of leukocyte biology·2022
Same author

Response to "Be alert to leukocyte antibodies when prescribing granulocyte transfusions".

Transfusion·2019
Same author

WBC alloimmunization: effects on the laboratory and clinical endpoints of therapeutic granulocyte transfusions.

Transfusion·2018
Same author

Efficacy of transfusion with granulocytes from G-CSF/dexamethasone-treated donors in neutropenic patients with infection.

Blood·2015
Same author

Effect of cord blood processing on transplantation outcomes after single myeloablative umbilical cord blood transplantation.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation·2014
Same author

Granulocyte transfusion therapy.

Journal of intensive care medicine·2013
Same journal

Pain in SCD-Many mechanisms and mysteries.

Seminars in hematology·2026
Same journal

The many facets of cardiopulmonary complications in sickle cell disease.

Seminars in hematology·2026
Same journal

Clonal hematopoiesis in the setting of sickle cell disease and its relevance to curative therapies.

Seminars in hematology·2026
Same journal

Treatment of myeloproliferative neoplasms: Exploring new horizons of who and when to cytoreduce in patients with polycythemia vera and essential thrombocytosis.

Seminars in hematology·2026
Same journal

Telomeres biology disorders: the past, the present and the future.

Seminars in hematology·2026
Same journal

Cardiovascular complications in patients with myeloproliferative neoplasms: What hematologists need to know.

Seminars in hematology·2026
See all related articles

Granulocyte transfusions, stimulated by granulocyte colony-stimulating factor (G-CSF), can increase neutrophil counts in patients with therapy-related neutropenia. However, randomized trials are needed to confirm their clinical effectiveness in fighting infections and improving survival.

Area of Science:

  • Hematology
  • Oncology
  • Infectious Diseases

Background:

  • Therapy-related neutropenia is a significant cause of patient morbidity and mortality.
  • Granulocyte transfusions are being re-evaluated as a treatment for neutropenia.
  • Granulocyte colony-stimulating factor (G-CSF) enables collection of large granulocyte doses from donors.

Purpose of the Study:

  • To evaluate the potential of G-CSF-stimulated granulocyte transfusions for treating therapy-related neutropenia.
  • To assess the efficacy of granulocytes collected from G-CSF-stimulated donors.

Main Methods:

  • Collection of granulocytes from donors stimulated with G-CSF.
  • Assessment of neutrophil count increase in patients.
  • Evaluation of granulocyte function using in vitro and in vivo measures.

Related Experiment Videos

Main Results:

  • G-CSF-stimulated granulocytes effectively increase patient neutrophil counts.
  • Collected granulocytes appear to function normally based on in vitro and in vivo assessments.
  • Existing clinical evidence is limited to case reports and small, non-uniform series.

Conclusions:

  • G-CSF-stimulated granulocyte transfusions show promise in raising neutrophil counts.
  • Further randomized controlled trials are essential to establish clinical efficacy in infection clearance and survival.
  • The clinical utility of this therapeutic approach requires definitive evidence from controlled studies.